drugset / Trial / NCT03481790

Lactoferrin Versus Ferrous Sulphate for Treatment of Iron Deficiency Anaemia During Pregnancy

NCT03481790

Phase 2 Completed 200 enrolled Ain Shams Maternity Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

This study evaluates the efficacy and tolerability of lactoferrin in contrast to ferrous sulphate in the context of iron deficiency anemia with pregnancy. Half of participants will receive lactoferrin, while the other half will receive ferrous sulphate.

Timeline

Start
2017-09-01
Primary completion
2018-03-05
Completion
2018-03-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Ferrous Sulfate Diagnostic / imaging agent 150 mg Oral
Subject Lactoferrin Protein / enzyme biologic 100 mg Oral
Subject folic acid Other / unclassified 150 mg Oral